Lebenthal Global Advisors’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$964K Buy
3,563
+387
+12% +$115K 0.14% 116
2025
Q4
$1.05M Buy
3,176
+319
+11% +$108K 0.16% 96
2025
Q3
$987K Buy
+2,857
New +$864K 0.17% 89
2025
Q2
Sell
-1,336
Closed -$700K 205
2025
Q1
$700K Buy
+1,336
New +$683K 0.13% 103
2022
Q2
Sell
-1,090
Closed -$555K 150
2022
Q1
$555K Sell
1,090
-44
-4% -$21.2K 0.24% 75
2021
Q4
$569K Sell
1,134
-55
-5% -$24.9K 0.23% 62
2021
Q3
$464K Buy
1,189
+1
+0.1% +$414 0.29% 63
2021
Q2
$475K Buy
1,188
+24
+2% +$9.57K 0.26% 74
2021
Q1
$433K Sell
1,164
-26
-2% -$9.01K 0.27% 64
2020
Q4
$417K Buy
+1,190
New +$399K 0.3% 42

Other funds holding UNH

Lebenthal Global Advisors's UNH Position: Q1 2026 in Review

Lebenthal Global Advisors increased its UnitedHealth (UNH) stake by 12% in Q1 2026, buying an estimated $115K and bringing the position to 3,563 shares worth $964K. The position accounts for 0.14% of the portfolio, ranked #116.

Lebenthal Global Advisors first reported a position in UNH in Q4 2020 and has held it in 10 quarters since. The position peaked at $1.05M in Q4 2025. 3,019 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Lebenthal Global Advisors held 3,563 shares of UnitedHealth worth $964K as of Q1 2026.
  • Lebenthal Global Advisors bought 387 UnitedHealth shares in Q1 2026, an estimated $115K.
  • UnitedHealth made up 0.14% of Lebenthal Global Advisors's portfolio in Q1 2026, its #116 holding.
  • Lebenthal Global Advisors first reported a position in UnitedHealth in Q4 2020 and has held it in 10 quarters since.
  • Lebenthal Global Advisors's UnitedHealth position peaked at $1.05M in Q4 2025.
  • 3,019 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Lebenthal Global Advisors's 13F filing for Q1 2026, filed 14 May 2026.